<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03989882</url>
  </required_header>
  <id_info>
    <org_study_id>HS1888</org_study_id>
    <nct_id>NCT03989882</nct_id>
  </id_info>
  <brief_title>Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults</brief_title>
  <official_title>Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oklahoma State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oklahoma State University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to determine the effects of wheat germ (WG)
      supplementation on gut health and subsequent effects on markers of inflammation and insulin
      resistance in overweight individuals. WG is a by-product of wheat processing and an excellent
      source of omega-3 fatty acids, vitamin E, and fiber. A few studies have shown the health
      benefits of WG including gut modulatory potential, but the prebiotic functions of WG in
      humans remain in question and warrant further investigation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy overweight (body mass index, BMI, between 25.0 - 30 kg/m2) between 18 to 45 years old
      regardless of gender will be recruited. They will be randomly assigned to receive two energy
      balls containing 30 grams of wheat germ or corn meal (control) in a 4-wk randomized
      controlled pilot trial. The energy balls will contain wheat germ or corn meal, peanut butter,
      honey and milk. Participants will be asked to consume two energy balls daily for 4 weeks.
      Anthropometric measures, questionnaires (medical, diet, physical activity and bowel habits),
      blood and fecal samples will be collected at baseline and at the end of the four week study.
      The investigator's primary outcome variables will be changes in fecal bacteria,
      immunoglobulin A, zonulin and short chain fatty acids while secondary outcome variables will
      be alterations in plasma markers of inflammation and insulin resistance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will not know their treatment assignment and energy balls will be in an opaque container.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal bacteria population</measure>
    <time_frame>Change from baseline fecal bacteria at 30 days</time_frame>
    <description>analyzed by 16sRNA sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal immunoglobulin A</measure>
    <time_frame>Change from baseline fecal immunoglobulin A at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal zonulin</measure>
    <time_frame>Change from baseline fecal zonulin at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal short chain fatty acids</measure>
    <time_frame>Change from baseline fecal shortchain fatty acids at 30 days</time_frame>
    <description>analyzed by gas chromatography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>Change from baselineblood glucose at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood glycated hemoglobin</measure>
    <time_frame>Change from baseline blood glycated hemoglobin at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood high sensitivity C-reactive protein</measure>
    <time_frame>Change from baseline blood high sensitivity C-reactive protein at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood insulin level</measure>
    <time_frame>Change from baselineblood insulin level at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Overweight</condition>
  <condition>Insulin Resistance</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Wheat germ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wheat germ energy balls containing 30 g of wheat germ, peanut butter, and honey to form 2 energy balls that is approximately 200 kcal. Two energy balls will be consumed daily for 30 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control energy ball containing 30 g of cornmeal, peanut butter, and honey to form 2 energy balls that is approximately 200 kcal. Two energy balls will be consumed daily for 30 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wheat germ energy ball</intervention_name>
    <description>wheat germ mixed other ingredients to make an energy ball</description>
    <arm_group_label>Wheat germ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>corresponding control without wheat germ</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy overweight (body mass index, BMI, between 25.0 - 30 kg/m2) 18-45 years old

        Exclusion Criteria:

        diagnosed diabetes, heart disease, and cancer tobacco use excessive alcohol use taking
        mega-doses of antioxidant/vitamin supplements or medications that could interfere with
        study endpoints such as antibiotics, anti-inflammatory, and glucose-lowering medications
        major surgery occurring within 6 months pregnant or lactating previous high intake of wheat
        germ or sensitivity to gluten and wheat products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edralin Lucas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Okklahoma State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edralin Lucas, PhD</last_name>
    <phone>(405)744-3132</phone>
    <email>edralin.a.lucas@okstate.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sam Emerson, PhD</last_name>
    <phone>(405)744-2303</phone>
    <email>sam.emerson@okstate.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nutritional Sciences Department, Oklahoma State University</name>
      <address>
        <city>Stillwater</city>
        <state>Oklahoma</state>
        <zip>74078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edralin Lucas, PhD</last_name>
      <phone>405-744-3132</phone>
      <email>edrali.a.lucas@okstate.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sam Emerson, PhD</last_name>
      <phone>(405)744-2303</phone>
      <email>sam.emerson@okstate.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 22, 2019</study_first_submitted>
  <study_first_submitted_qc>June 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>June 17, 2019</last_update_submitted>
  <last_update_submitted_qc>June 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wheat germ</keyword>
  <keyword>overweight</keyword>
  <keyword>gut microbiome</keyword>
  <keyword>inflammation</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

